Cécile Gaujoux-Viala

Summary

Country: France

Publications

  1. doi request reprint Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
    Cécile Gaujoux-Viala
    Department of Rheumatology, Nîmes University Hospital EA 2415, Montpellier I University, Nimes, France
    Ann Rheum Dis 73:510-5. 2014
  2. doi request reprint Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohort
    Cécile Gaujoux-Viala
    Lorraine University, Paris Descartes University, Nancy, France
    Rheumatology (Oxford) 52:832-8. 2013
  3. ncbi request reprint [The main directions in case of polyarthritis]
    Cécile Gaujoux-Viala
    Universite Montpellier 1, CHU de Nimes, Hopital Caremeau, Service de Rhumatologie, 30000 Nimes, France
    Rev Prat 62:1069-76. 2012
  4. doi request reprint Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI
    Cécile Gaujoux-Viala
    Rheumatology Department, Groupe Hospitalier Pitie Salpetriere, Paris 6 university Pierre et Marie Curie, AP HP, 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Joint Bone Spine 79:149-55. 2012
  5. doi request reprint Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohort
    Cécile Gaujoux-Viala
    Groupe Hospitalier Pitie Salpetriere, Service de Rhumatologie, 83 Boulevard de l hopital, Paris Cedex 13, France
    Rheumatology (Oxford) 51:1648-54. 2012
  6. pmc Efficacy and safety of steroid injections for shoulder and elbow tendonitis: a meta-analysis of randomised controlled trials
    C Gaujoux-Viala
    Paris Descartes University, Medicine Faculty, UPRES EA 4058, APHP, Rheumatology B Department, Cochin Hospital, 75014 Paris, France
    Ann Rheum Dis 68:1843-9. 2009
  7. doi request reprint Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort
    Cécile Gaujoux-Viala
    INSERM, CIC EC CIE6, Nancy, France
    J Rheumatol 38:1576-84. 2011
  8. doi request reprint Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
    Cécile Gaujoux-Viala
    Hopital Pitie Salpetriere, Service de Rhumatologie, 83 Boulevard de l hopital, 75651 Paris Cedex 13, France
    Ann Rheum Dis 69:1004-9. 2010
  9. doi request reprint Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort
    Cécile Gaujoux-Viala
    Correspondence to Cécile Gaujoux Viala, Université Paris 6 Pierre and Marie Curie, AP HP, Groupe Hospitalier Pitie Salpetriere, Service de Rhumatologie, 83 boulevard de l Hôpital 75651 Paris cedex 13, France
    Ann Rheum Dis 71:1478-83. 2012
  10. doi request reprint Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis
    Athan Baillet
    Rheumatology Department, CHU Hopital Sud, Grenoble Teaching Hospital, avenue de Kimberley, BP 338, 38434 Echirolles Cedex, France
    Rheumatology (Oxford) 50:1137-47. 2011

Detail Information

Publications15

  1. doi request reprint Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
    Cécile Gaujoux-Viala
    Department of Rheumatology, Nîmes University Hospital EA 2415, Montpellier I University, Nimes, France
    Ann Rheum Dis 73:510-5. 2014
    ..To update a previous systematic review assessing the efficacy of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) in rheumatoid arthritis (RA)...
  2. doi request reprint Who are the patients with early arthritis with worse than death scores on the EQ-5D? Results from the ESPOIR cohort
    Cécile Gaujoux-Viala
    Lorraine University, Paris Descartes University, Nancy, France
    Rheumatology (Oxford) 52:832-8. 2013
    ..We aimed to describe patients with early arthritis (EA) and EQ-5D < 0, a state worse than death, at baseline and over 2 years and determine aspects of EA associated with a negative score...
  3. ncbi request reprint [The main directions in case of polyarthritis]
    Cécile Gaujoux-Viala
    Universite Montpellier 1, CHU de Nimes, Hopital Caremeau, Service de Rhumatologie, 30000 Nimes, France
    Rev Prat 62:1069-76. 2012
    ..The rapid institution of a disease-modifying antirheumatic drug can allow obtain a remission, mproves clinical outcomes and reduces the accrual of joint damage and disability...
  4. doi request reprint Evaluating disease activity in rheumatoid arthritis: which composite index is best? A systematic literature analysis of studies comparing the psychometric properties of the DAS, DAS28, SDAI and CDAI
    Cécile Gaujoux-Viala
    Rheumatology Department, Groupe Hospitalier Pitie Salpetriere, Paris 6 university Pierre et Marie Curie, AP HP, 83, Boulevard de l Hopital, 75651 Paris Cedex 13, France
    Joint Bone Spine 79:149-55. 2012
    ..To evaluate and compare four composite indices for assessing the activity of rheumatoid arthritis (RA)...
  5. doi request reprint Evidence of the symptomatic and structural efficacy of methotrexate in daily practice as the first disease-modifying drug in rheumatoid arthritis despite its suboptimal use: results from the ESPOIR early synovitis cohort
    Cécile Gaujoux-Viala
    Groupe Hospitalier Pitie Salpetriere, Service de Rhumatologie, 83 Boulevard de l hopital, Paris Cedex 13, France
    Rheumatology (Oxford) 51:1648-54. 2012
    ..To describe the use of MTX in early arthritis (EA) in daily clinical practice and to evaluate its 6-month symptomatic efficacy and 12-month structural efficacy...
  6. pmc Efficacy and safety of steroid injections for shoulder and elbow tendonitis: a meta-analysis of randomised controlled trials
    C Gaujoux-Viala
    Paris Descartes University, Medicine Faculty, UPRES EA 4058, APHP, Rheumatology B Department, Cochin Hospital, 75014 Paris, France
    Ann Rheum Dis 68:1843-9. 2009
    ..To assess the efficacy and safety of steroid injections for patients with tendonitis of the shoulder or elbow...
  7. doi request reprint Comparison of the EQ-5D and the SF-6D utility measures in 813 patients with early arthritis: results from the ESPOIR cohort
    Cécile Gaujoux-Viala
    INSERM, CIC EC CIE6, Nancy, France
    J Rheumatol 38:1576-84. 2011
    ..Our objective was to compare the EuroQol EQ-5D health outcome measure and the SF-6D and to investigate their relationship to clinical variables in a large prospective cohort of patients with EA...
  8. doi request reprint Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
    Cécile Gaujoux-Viala
    Hopital Pitie Salpetriere, Service de Rhumatologie, 83 Boulevard de l hopital, 75651 Paris Cedex 13, France
    Ann Rheum Dis 69:1004-9. 2010
    ....
  9. doi request reprint Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort
    Cécile Gaujoux-Viala
    Correspondence to Cécile Gaujoux Viala, Université Paris 6 Pierre and Marie Curie, AP HP, Groupe Hospitalier Pitie Salpetriere, Service de Rhumatologie, 83 boulevard de l Hôpital 75651 Paris cedex 13, France
    Ann Rheum Dis 71:1478-83. 2012
    ..The authors aimed to compare the responsiveness of the EQ-5D and the SF-6D in a large prospective cohort of patients with EA...
  10. doi request reprint Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis
    Athan Baillet
    Rheumatology Department, CHU Hopital Sud, Grenoble Teaching Hospital, avenue de Kimberley, BP 338, 38434 Echirolles Cedex, France
    Rheumatology (Oxford) 50:1137-47. 2011
    ..To evaluate the reproducibility of US and to compare its efficacy with that of MRI and conventional radiography (CR) for the detection of bone erosion in RA patients...
  11. doi request reprint Impact of co-morbidities on measuring indirect utility by the Medical Outcomes Study Short Form 6D in lower-limb osteoarthritis
    Kossar Hosseini
    Université de Lorraine, Paris Descartes University, APEMAC, EA 4360, F 54 000, France
    Best Pract Res Clin Rheumatol 26:627-35. 2012
    ..Co-morbidities can influence generic measurement of health indirect utility. We investigated their impact to assess indirect utility with the Medical Outcomes Study Short Form 6D (SF-6D) in patients with osteoarthritis (OA)...
  12. doi request reprint Clinical outcomes in psoriatic arthritis: A systematic literature review
    Penélope Esther Palominos
    Paris Descartes University, UPRES EA 4058, AP HP, Cochin Hospital, Paris, France
    Arthritis Care Res (Hoboken) 64:397-406. 2012
    ..The objective of this work was to assess reporting of outcomes in PsA, including patient-reported outcomes (PROs) in recent publications...
  13. doi request reprint [The rheumatoid hand]
    Julien Henry
    Universite Pierre et Marie Curie Paris 6, Groupe Hospitalier La Pitié Salpêtrière, AP HP, Service de Rhumatologie, 75651 Paris Cedex, France
    Presse Med 42:1607-15. 2013
    ..Patients with RA should be closely monitored in order to detect joint damages necessitating physical therapist or hand surgeon consultation...
  14. ncbi request reprint [Medical and economic aspects of rheumatoid arthritis]
    Bruno Fautrel
    Université Paris 6 Pierre and Marie Curie GRC 08 EEMOIS, Rhumatologie, AP HP, Groupe Hospitalier Pitie Salpetriere, Paris Cedex 13
    Bull Acad Natl Med 196:1295-305; discussion 1305-6. 2012
    ..In contrast, they have not yet been shown to reduce the number of patients who become disabled, and their cost-effectiveness ratio thus tends to be unfavorable...
  15. doi request reprint Scleritis: a paradoxical effect of etanercept? Etanercept-associated inflammatory eye disease
    Cécile Gaujoux-Viala
    Pierre et Marie Curie University, AP HP, Department of Rheumatology, Pitie Salpetriere Hospital, corrected Paris, France
    J Rheumatol 39:233-9. 2012
    ..To describe 3 cases of scleritis associated with etanercept use for rheumatoid arthritis (RA) and to review the literature related to inflammatory eye diseases associated with the use of etanercept...